BioCentury
ARTICLE | Clinical News

Pharmalgen regulatory update

January 2, 2012 8:00 AM UTC

The U.K.'s NICE issued final draft guidance recommending ALK-Abello's Pharmalgen to treat IgE-mediated bee and wasp venom allergy. The product is recommended for those who have had a severe systemic ...